To determine whether LOH contributes to the decreased expression of GLS2 in HCC, Taqman real-time PCR copy number assays were employed to determine the copy number of the gene in aforementioned 21 primary HCCs and their adjacent non-tumor liver tissues. This evidence concerns the gene GLS2 and neoplasm.